Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies

OBJECTIVE: The objective of this study was to confirm the efficacy of low-dose mizoribine (MZR), an inhibitor of inosine monophosphate dehydrogenase, as part of synchronized methotrexate (MTX) therapy for rheumatoid arthritis (RA) patients with an inadequate response to various combination therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Keigo, Watanabe, Kozo, Hirai, Takuya, Tanji, Kana, Miyashita, Tomoko, Nakajima, Shihoko, Uomori, Kaori, Morimoto, Shinji, Takamori, Kenji, Ogawa, Hideoki, Takasaki, Yoshinari, Sekigawa, Iwao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491807/
https://www.ncbi.nlm.nih.gov/pubmed/28502927
http://dx.doi.org/10.2169/internalmedicine.56.7886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491807/
https://www.ncbi.nlm.nih.gov/pubmed/28502927
http://dx.doi.org/10.2169/internalmedicine.56.7886

Ejemplares similares